IPDataLab
IPDataLab is an IP data intelligence provider linking FDA-approved drug records (PurpleBook/OrangeBook), Standard Essential Patents from 15+ SSOs, and U.S. Office Action data, serving pharmaceutical companies, IP professionals, and data developers through subscription and bulk-data channels.
- Company typePrivate
- Founded2021
- HeadquartersEdina, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What IPDataLab does
IPDataLab is a privately held, U.S.-based intellectual property data intelligence provider that curates and links patent records to commercial activity indicators — most notably FDA-approved drug data — for pharmaceutical, IP professional, and data developer buyers. Headquartered in Edina, Minnesota with 1-10 employees, the company was co-founded by Chris Holt (formerly VP of Patent Analytics at LexisNexis IP and founder of PatentCore, which was sold to LexisNexis in 2014) and Miao Li (a qualified Chinese patent attorney who led global patent search product management at LexisNexis). IPDataLab operates a five-product portfolio that addresses gaps left by standard patent databases: PurpleBook Patent Data (biological drugs approved by the FDA), OrangeBook Patent Data (chemical drugs), Standard Essential Patent Data covering declared SEPs from more than 15 Standard Setting Organizations, Full Text U.S. Office Actions, and U.S. Office Action Mention Data with 20+ years of historical coverage and monthly updates. Underlying technology combines automated data retrieval from hard-to-reach sources with manual curation and quality assurance performed by a team with patent attorney and software product management experience, supported by proprietary algorithms (most notably a patent expiry-date calculator that accounts for patent term extension, patent term adjustment, terminal disclaimers, and maintenance fee status) and enriched metadata fields not available in standard databases (biological targets, indications, PTE requested vs. granted days, claim charts).\n\nIPDataLab monetizes the data through two subscription channels — a self-serve monthly online search platform (including a Pharmspot-branded PurpleBook portal) and annual bulk data licenses for system integration with redistribution permitted in most cases — alongside consulting and custom data product development for partners. Pricing is contact-only across all tiers, and enterprise sales are handled through direct outreach and demo requests. The go-to-market blends product-led self-serve for individual users with sales-led enterprise engagement and channel partnerships, exemplified by the January 2022 Lighthouse IP partnership for distributing drug-patent linkage metadata. Customer segments span pharmaceutical and biotechnology companies (primary, focused on FTO analysis and generic entry planning), intellectual property professionals and patent attorneys, developers and technology companies integrating patent data into commercial systems, and IP data marketplaces and aggregators seeking differentiated datasets. The company self-describes as adopting a "laboratory model" that emphasizes fast and iterative releases of prototypes and applications, with a pipeline of contract-developed innovations supplied to selected commercial providers.
IPDataLab firmographics
Firmographics- Name
- IPDataLab
- Legal name
- IPDataLab
- Website
- https://ipdatalab.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- IPDataLab is an IP data intelligence provider linking FDA-approved drug records (PurpleBook/OrangeBook), Standard Essential Patents from 15+ SSOs, and U.S. Office Action data, serving pharmaceutical companies, IP professionals, and data developers through subscription and bulk-data channels.
- Ownership category
- akta.pro rank
IPDataLab industry classification
Industry- Product category
- Intellectual Property Data Intelligence
- NAICS
- Web Search Portals and All Other Information Services (51929)
- akta.pro primary industry
- IP Search, Watch & Competitive Intelligence (BPAHAMAI)
- akta.pro secondary industries
- IP & Patent Information Publishing (Patent/Litigation Analytics, Prior Art) (MPAJACAK), IP Due Diligence & Freedom-to-Operate (FTO) Analysis (BPAHAMAG)
Keywords
Where IPDataLab is headquartered
LocationHeadquarters
- HQ city
- Edina
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
IPDataLab business model
Business model- GTM type
- B2B
- Offering type
- Software
Revenue model
- Data Subscriptions (Online Search Access): Subscription-based access to online research platforms hosted by IPDataLab. Customers pay for electronic access to search and interact with data sets including PurpleBook, OrangeBook, SEP, Full Text Office Actions, and Mention databases. Monthly subscriptions with immediate access upon payment.
- Bulk Data / Backfile Services: Bulk data downloads for integration into customers' own commercial or research systems. Pricing provided upon contact. Redistribution of data is permitted in most cases. Includes backfile historical data plus ongoing updates.
- Strategic Partnership & Consulting: Consulting and collaboration services for companies wanting to build custom data solutions. Working with large and small companies and startups to help them reach broader markets. Revenue from contract development of custom data products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Online Search Access Subscription |
| Subscription | Annual | Bulk Data / Backfile and Updates |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
IPDataLab product offering
Product offeringCore offering
IPDataLab provides intellectual property data intelligence by linking individual patents to indicators of corresponding commercial activity, particularly FDA-approved drug information. The company offers curated, enriched patent databases—including PurpleBook (biological drugs), OrangeBook (chemical drugs), Standard Essential Patents, full-text U.S. Office Actions, and Office Action citation mentions—delivered through both a web-based search platform for individual users and bulk data services for integration into enterprise systems.
Product overview
IPDataLab provides intellectual property data intelligence through bulk data services and web-based search platforms. The portfolio consists of five core products: Purple Book Patent Data (for biological drugs) and Orange Book Patent Data (for chemical drugs) link FDA-approved drugs with associated patents; Standard Essential Patent Data covers declared SEPs from major standards organizations; Full Text U.S. Office Actions provides complete office action documents; and U.S. Office Action Mention Data extracts cited references with rejection reasons. These products can be accessed via online subscription or bulk data download for system integration.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Over 20 years of historical Office Action data plus monthly updates available for integration
- +4 more outcomes
Companies that use IPDataLab
Customer profileSegments4 records
IPDataLab technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
IPDataLab partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Lighthouse IPcoreLighthouse IP partnered with IPDataLab to deliver high-value metadata linking patent records to US-FDA approved chemical and biological drug information. The partnership addresses market demand for a streamlined path to integrating both common and uncommon drug approval information into existing patent data systems. Lighthouse IP distributes IPDataLab's enriched drug-patent linkage data to its customers, extending market reach for IPDataLab's data products.
Scale indicators6 records
Recent moves5 records
Expansion highlights4 records
IPDataLab competitors and assessment
Company assessmentDirect peers
- Minesoft: Specialist patent search and intelligence provider with patented citation extraction and alerting capabilities; comparable to IPDataLab's Mention DB and SEP offerings as a focused IP data vendor serving patent attorneys and competitive intelligence teams.
- PatSnap: AI-driven patent analytics platform offering search, landscaping, and competitive intelligence; comparable in serving R&D and IP teams with enriched patent metadata, though with a different go-to-market and broader product breadth than IPDataLab.
- DrugPatentWatch: Direct competitor in the drug-patent linkage space, providing Orange Book and Purple Book-adjacent patent and exclusivity data for pharmaceutical generic entry and lifecycle management. Closest comparable on the FDA-drug-patent product surface.
- Lighthouse IP: IP data aggregator and integration partner that distributes IPDataLab's drug-patent linkage data through its platform; a peer by virtue of operating in the same enriched-patent-data category and a current channel partner of IPDataLab.
Emerging players
- Relecura: Patent analytics platform specializing in patent valuation, landscaping, and technology intelligence using AI; comparable to IPDataLab on patent metadata enrichment and analytics depth, particularly for technology standards and SEP-related analysis.
- Gridlogics (PatentsKart): Patent search and analytics SaaS vendor offering patent landscaping and visualization tools; smaller-scale competitor comparable to IPDataLab in serving IP professionals with enriched patent data and analytics.
Broad incumbents
- Questel (Orbit Intelligence): Global IP data and analytics provider offering Orbit Intelligence for patent search, landscaping, and competitive intelligence; comparable to IPDataLab's SEP and patent datasets with broader geographic coverage and enterprise integrations.
- Anaqua (IPfolio): IP management and analytics platform serving corporate IP departments; comparable on patent analytics and data integrations, with a broader IPMS offering that competes for the same pharma IP team budgets as IPDataLab's FTO-oriented datasets.
- Clarivate (Derwent Innovation / PatentSight): Largest commercial patent analytics vendor offering Derwent Innovation, PatentSight, and Cortellis; competes broadly with IPDataLab's patent datasets and bundles in pharma IP, competitive intelligence, and lifecycle management. Most directly comparable on Orange/Purple Book-adjacent drug-patent intelligence.
- LexisNexis (PatentAdvisor / TotalPatent): Former employer of IPDataLab's founders and the most directly comparable enterprise patent analytics suite. LexisNexis's PatentAdvisor (which Holt previously led) competes on prosecution analytics and integrates patent data with broader legal workflows.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
IPDataLab social profiles
Digital presenceIPDataLab financial estimates
Financial estimateRevenue estimate
Valuation estimate
IPDataLab leadership team
Management profileNumber of profiles
IPDataLab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IPDataLab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IPDataLab
What does IPDataLab do?
IPDataLab provides intellectual property data intelligence by linking individual patents to indicators of corresponding commercial activity, particularly FDA-approved drug information. The company offers curated, enriched patent databases—including PurpleBook (biological drugs), OrangeBook (chemical drugs), Standard Essential Patents, full-text U.S. Office Actions, and Office Action citation mentions—delivered through both a web-based search platform for individual users and bulk data services for integration into enterprise systems.
Is IPDataLab a public or private company?
IPDataLab is a private company. It is currently operating.
When was IPDataLab founded?
IPDataLab was founded in 2021. It employs 1 to 10 people.
Where is IPDataLab based?
IPDataLab is headquartered in Edina, United States, in the North America region.
How does IPDataLab make money?
Three revenue lines are on record. Data Subscriptions (Online Search Access) is the primary driver. The others are bulk Data / Backfile Services and strategic Partnership & Consulting.
Who are IPDataLab's main competitors?
Direct peers on record are Minesoft, PatSnap, DrugPatentWatch and Lighthouse IP. Emerging players are Relecura and Gridlogics (PatentsKart). Broad incumbents are Questel (Orbit Intelligence), Anaqua (IPfolio), Clarivate (Derwent Innovation / PatentSight) and LexisNexis (PatentAdvisor / TotalPatent).
Does IPDataLab have an API?
No public API is recorded for IPDataLab.
What industry is IPDataLab in?
IPDataLab's product category is Intellectual Property Data Intelligence. Its primary akta.pro industry code is BPAHAMAI, IP Search, Watch & Competitive Intelligence, with a secondary code of MPAJACAK, IP & Patent Information Publishing (Patent/Litigation Analytics, Prior Art). Its NAICS code is 51929.